DIPEPTIDYL PEPTIDASE-4 INHIBITOR HAS BENEFICIAL EFFECTS ON POST-MYOCARDIAL INFARCTION HEART IN DIABETIC MICE

被引：0
|
作者：
Kubota, Akihiko [1 ]
Hasegawa, Hiroshi [1 ]
Kameda, Yoshihito [1 ]
Yuka, Kobara [1 ]
Tadokoro, Hiroyuki [1 ]
Kobayashi, Yoshio [1 ]
Komuro, Issei [1 ]
Takano, Hiroyuki [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(13)60596-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E596 / E596
页数：1
相关论文
共 50 条
  • [41] A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
    Jeong, Su Hyun
    Vorachitti, Merica
    Fuentes, Fernando
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [42] A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
    Yamaguchi, Takehiro
    Watanabe, Ayano
    Tanaka, Masako
    Shiota, Masayuki
    Osada-Oka, Mayuko
    Sano, Soichi
    Yoshiyama, Minoru
    Miura, Katsuyuki
    Kitajima, Shojiro
    Matsunaga, Shinji
    Tomita, Shuhei
    Iwao, Hiroshi
    Izumi, Yasukatsu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2019, 139 (02) : 112 - 119
  • [43] Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor reverses diabetes in NOD mice
    Suarez-Pinzon, Wilma L.
    Cembrowski, George S.
    Rabinovitch, Alex
    DIABETES, 2008, 57 : A444 - A444
  • [44] Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients
    Fujiwara, Takayuki
    Yoshida, Masashi
    Nakamura, Tomohiro
    Sakakura, Kenichi
    Wada, Hiroshi
    Arao, Kenshiro
    Katayama, Takuji
    Funayama, Hiroshi
    Sugawara, Yoshitaka
    Mitsuhashi, Takeshi
    Kakei, Masafumi
    Momomura, Shin-ichi
    Ako, Junya
    HEART AND VESSELS, 2015, 30 (05) : 696 - 701
  • [45] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats
    Zhang, Qian
    Xiao, Xinhua
    Zheng, Jia
    Li, Ming
    Yu, Miao
    Ping, Fan
    Wang, Tong
    Wang, Xiaojing
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (05) : 1378 - 1387
  • [46] Effects of Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
    Yamamoto, Masayoshi
    Seo, Yoshihiro
    Yamada, Yu
    Nakagawa, Taishi
    Nakatsukasa, Tomofumi
    Sugano, Akinori
    Hamada, Yoshie
    Machino, Tomoko
    Ishizu, Tomoko
    Aonuma, Kazutaka
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S198 - S198
  • [47] Research strategy for alogliptin, a dipeptidyl peptidase-4 inhibitor, as a novel anti-diabetic agent
    Matsuo, Takanori
    Takeuchi, Koji
    Yamada, Yukio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 41P - 41P
  • [48] Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients
    Takayuki Fujiwara
    Masashi Yoshida
    Tomohiro Nakamura
    Kenichi Sakakura
    Hiroshi Wada
    Kenshiro Arao
    Takuji Katayama
    Hiroshi Funayama
    Yoshitaka Sugawara
    Takeshi Mitsuhashi
    Masafumi Kakei
    Shin-ichi Momomura
    Junya Ako
    Heart and Vessels, 2015, 30 : 696 - 701
  • [49] Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study
    Kim, N. H.
    Choi, J.
    Choi, K. M.
    Baik, S. H.
    Lee, J.
    Kim, S. G.
    DIABETES & METABOLISM, 2018, 44 (04) : 361 - 367
  • [50] Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
    Kang, Eugene Yu-Chuan
    Kang, Chunya
    Wu, Wei-Chi
    Sun, Chi-Chin
    Chen, Kuan-Jen
    Lai, Chi-Chun
    Chen, Tien-Hsing
    Hwang, Yih-Shiou
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
12345